From f4821865a3e7ebc18bfc3a0569a9fb959049e8a1 Mon Sep 17 00:00:00 2001 From: Eli White Date: Sun, 26 Jul 2020 16:16:23 +0000 Subject: [PATCH] Add new CDC file --- cdcupdates/management/20-07-26.txt | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/cdcupdates/management/20-07-26.txt b/cdcupdates/management/20-07-26.txt index 33d5a76e..454dda9e 100644 --- a/cdcupdates/management/20-07-26.txt +++ b/cdcupdates/management/20-07-26.txt @@ -57,7 +57,7 @@ Severe (dyspnea, hypoxia, or >50% lung involvement on imaging): 14% Critical (respiratory failure, shock, or multiorgan system dysfunction): 5% In this study, all deaths occurred among patients with critical illness, and the overall case fatality rate was 2.3%.36 The case fatality rate among patients with critical disease was 49%.36 Among children in China, illness severity was lower with 94% having asymptomatic, mild, or moderate disease; 5% having severe disease; and <1% having critical disease.16 Among U.S. COVID-19 cases with known disposition, the proportion of persons who were hospitalized was 19%.37 The proportion of persons with COVID-19 admitted to the intensive care unit (ICU) was 6%.37 Clinical Progression -Among patients who developed severe disease, the medium time to dyspnea from the onset of illness or symptoms ranged from 5 to 8 days, the median time to acute respiratory distress syndrome (ARDS) from the onset of illness or symptoms ranged from 8 to 12 days, and the median time to ICU admission from the onset of illness or symptoms ranged from 10 to 12 days.5,6,10,11 Clinicians should be aware of the potential for some patients to rapidly deteriorate one week after illness onset. Among all hospitalized patients, a range of 26% to 32% of patients were admitted to the ICU.6,8,11 Among all patients, a range of 3% to 17% developed ARDS compared to a range of 20% to 42% for hospitalized patients and 67% to 85% for patients admitted to the ICU.1,4-6,8,11 Mortality among patients admitted to the ICU ranges from 39% to 72% depending on the study and characteristics of patient population.5,8,10,11 The median length of hospitalization among survivors was 10 to 13 days.1,6,8 +Among patients who developed severe disease, the median time to dyspnea from the onset of illness or symptoms ranged from 5 to 8 days, the median time to acute respiratory distress syndrome (ARDS) from the onset of illness or symptoms ranged from 8 to 12 days, and the median time to ICU admission from the onset of illness or symptoms ranged from 10 to 12 days.5,6,10,11 Clinicians should be aware of the potential for some patients to rapidly deteriorate one week after illness onset. Among all hospitalized patients, a range of 26% to 32% of patients were admitted to the ICU.6,8,11 Among all patients, a range of 3% to 17% developed ARDS compared to a range of 20% to 42% for hospitalized patients and 67% to 85% for patients admitted to the ICU.1,4-6,8,11 Mortality among patients admitted to the ICU ranges from 39% to 72% depending on the study and characteristics of patient population.5,8,10,11 The median length of hospitalization among survivors was 10 to 13 days.1,6,8 Risk Factors for Severe Illness Age is a strong risk factor for severe illness, complications, and death.1,6,8,14,36-40 Among >44,000 confirmed cases of COVID-19 in China, the case fatality rate was highest among older persons: ≥80 years, 14.8%; 70–79 years, 8.0%; 60–69 years, 3.6%; 50–59 years, 1.3%; 40–49 years, 0.4%; <40 years, 0.2%.36,41 In early U.S. epidemiologic data, case fatality was highest in persons aged ≥85 years (range 10%–27%), followed by those aged 65-84 years (3%–11%), aged 55-64 years (1%–3%), and aged <55 years (<1%).37 Patients in China with no reported underlying medical conditions had an overall case fatality of 0.9%. Case fatality was higher for patients with comorbidities: 10.5% for those with cardiovascular disease, 7.3% for those with diabetes, and approximately 6% for those with chronic respiratory disease, or cancer.1,6,14,36,38,41,42    Prior stroke, diabetes, chronic lung disease, and chronic kidney disease have all been associated with increased illness severity and adverse outcomes. Serious heart conditions, including heart failure, coronary artery disease, congenital heart disease, cardiomyopathies, and pulmonary hypertension, may put people at higher risk for severe illness from COVID-19. People with hypertension may be at an increased risk for severe illness from COVID-19 and should continue to take their medications as prescribed. At this time, people whose only underlying medical condition is hypertension are not considered to be at higher risk for severe illness from COVID-19.43,44